Quick10K

⚲

Ocean Bio Chem

Filings

10-Q	2020-06-30	Filed 2020-08-14
10-Q	2020-03-31	Filed 2020-05-15
10-K	2019-12-31	Filed 2020-03-30
10-Q	2019-09-30	Filed 2019-11-14
10-Q	2019-06-30	Filed 2019-08-14
10-Q	2019-03-31	Filed 2019-05-15
10-K	2018-12-31	Filed 2019-03-29
10-Q	2018-09-30	Filed 2018-11-14
10-Q	2018-06-30	Filed 2018-08-14
10-Q	2018-03-31	Filed 2018-05-15
10-K	2017-12-31	Filed 2018-03-30
10-Q	2017-09-30	Filed 2017-11-14
10-Q	2017-06-30	Filed 2017-08-14
10-Q	2017-03-31	Filed 2017-05-15
10-K	2016-12-31	Filed 2017-03-31
10-Q	2016-09-30	Filed 2016-11-14
10-Q	2016-06-30	Filed 2016-08-12
10-Q	2016-03-31	Filed 2016-05-16
10-K	2015-12-31	Filed 2016-03-30
10-Q	2015-09-30	Filed 2015-11-13
10-Q	2015-06-30	Filed 2015-08-14
10-Q	2015-03-31	Filed 2015-05-15
10-K	2014-12-31	Filed 2015-03-31
10-Q	2014-09-30	Filed 2014-11-14
10-Q	2014-06-30	Filed 2014-08-14
10-Q	2014-03-31	Filed 2014-05-15
10-K	2013-12-31	Filed 2014-03-31
10-Q	2013-09-30	Filed 2013-11-14
10-Q	2013-06-30	Filed 2013-08-14
10-Q	2013-03-31	Filed 2013-05-15
10-K	2012-12-31	Filed 2013-04-01
10-Q	2012-09-30	Filed 2012-11-14
10-Q	2012-06-30	Filed 2012-08-14
10-Q	2012-03-31	Filed 2012-05-15
10-K	2011-12-31	Filed 2012-03-30
10-Q	2011-09-30	Filed 2011-11-14
10-Q	2011-06-30	Filed 2011-08-15
10-Q	2011-03-31	Filed 2011-05-13
10-K	2010-12-31	Filed 2011-03-31
10-Q	2010-09-30	Filed 2010-11-12
10-Q	2010-06-30	Filed 2010-08-13
10-Q	2010-05-13	Filed 2010-05-13
10-K	2009-12-31	Filed 2010-03-30

Reports

8-K	2020-08-26	Other Events
8-K	2020-08-10	Exhibits
8-K	2020-07-17	Earnings, Exhibits
8-K	2020-05-29
8-K	2020-05-26
8-K	2020-05-15
8-K	2020-04-27
8-K	2020-04-27
8-K	2020-03-19
8-K	2020-01-28
8-K	2019-11-14
8-K	2019-08-14
8-K	2019-06-03
8-K	2019-03-22
8-K	2018-11-14
8-K	2018-08-31
8-K	2018-08-14
8-K	2018-08-06
8-K	2018-05-18
8-K	2018-05-15
8-K	2018-04-26
8-K	2018-03-30
8-K	2018-03-19
8-K	2018-01-17

Ocean Bio Chem Financials

OBCI Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin


Comps ($'000 TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
Nexeo Solutions (NXEO)	757,054	11%	9.1	1%	2,179,100	1,359,600	4,040,400	451,900	19,100	169,200	1,533,454
Innophos Holdings (IPHS)	681,397	18%	20.0	2%	875,844	537,946	758,544	135,019	21,366	49,446	990,666
Hawkins (HWKN)	452,894	18%	9.4	7%	393,042	163,607	548,581	98,498	26,958	55,485	523,838
OMNOVA Solutions (OMN)	253,536	23%	10.7	1%	583,900	524,200	759,500	178,300	6,000	50,400	539,836
Foamix Pharmaceuticals (FOMX)	187,642	74%	-2.8	-70%	81,583	28,054	1,168	860	-57,358	-57,278	159,797
MediWound (MDWD)	118,500			0%	35,276		0	0	0	0	118,411
Natural Alternatives International (NAII)	59,541	16%	4.0	4%	115,237	37,832	130,953	20,796	4,078	7,694	31,041
Mannatech (MTEX)	39,837	80%	1.4	2%	66,806	42,161	118,340	95,087	1,185	5,740	8,031
China Jo-Jo Drugstores (CJJD)	39,524	24%	-45.8	-3%	87,150	65,526	111,004	26,449	-2,744	-481	22,025
Ocean Bio Chem (OBCI)	30,878	38%	8.3	7%	39,134	9,050	32,529	12,344	2,849	3,758	31,094
Cyanotech (CYAN)	18,636	41%	31.4	-3%	32,437	17,093	31,864	13,083	-1,090	788	24,748
CTI Industries (CTIB)	8,286	16%	-2.5	-16%	32,897	30,950	33,481	5,342	-5,142	-3,674	9,028
Fuwei Films (FFHL)	6,793	14%	4.5	-2%	454,682	257,851	303,573	42,152	-8,960	-8,960	-40,115
Chromadex (CDXC)	249	55%	0.4	-54%	43,139	15,997	33,202	18,304	-23,294	-21,662	-8,507
HEXO (HEXO)
Aphria (APHA)
Canopy Growth Corporation (CGC)
Cronos Group (CRON)
Aurora Cannabis (ACB)
Happiness Biotech (HAPP)				0%	65,679	4,763	0	0	0	0	-14,801


Balance Sheet ($'000)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	539	809	585	685	1,128	775	1,508	534	1,006	679	3,072	2,830	2,714	1,828	3,063	2,012	2,847	933	2,468	2,436	1,796	1,086	4,070	3,399	868	3,434	2,747	5,050	3,688	4,398	3,734	2,727	3,287	3,986
Accounts Receivable	3,510	5,487	2,563	3,051	2,964	5,912	2,931	3,206	3,868	6,881	4,414	2,968	4,217	6,154	4,850	3,482	4,012	7,607	5,092	4,090	5,566	9,414	4,932	4,779	6,248	8,454	4,964	5,003	9,072	10,792	5,659	6,693	8,554	10,254
Inventory	9,184	10,660	9,628	9,935	9,145	9,535	9,257	10,087	9,690	8,598	7,368	8,764	7,950	8,794	8,109	10,097	9,105	9,377	7,915	9,066	8,800	8,955	8,601	10,166	10,209	10,124	9,074	9,968	10,134	11,653	12,086	12,525	11,683	11,408
PP&E	5,298	5,215	5,213	5,141	13,406	13,541	13,861	13,980	14,189	14,336	14,373	14,517	14,810	15,009	15,090	15,371	15,771	15,946	16,098	16,137	16,217	16,286	16,472	17,376	18,964	19,993	21,711	22,287	22,632	22,891	23,070	23,329	23,454	23,552
Assets	20,206	23,974	19,879	20,581	20,279	23,188	21,010	21,321	21,797	23,668	22,243	22,559	22,764	24,476	23,980	24,185	24,229	25,997	23,989	24,163	24,311	27,210	25,671	27,517	27,278	34,399	31,991	32,857	35,493	40,583	35,235	36,670	37,189	39,134
Accounts Payable	1,055	2,712	1,162	1,321	1,577	2,275	1,431	1,556	1,591	2,266	1,014	1,491	1,348	2,397	1,440	1,996	1,410	2,618	1,102	2,119	1,787	2,994	1,512	2,547	2,230	2,776	1,807	1,929	2,546	3,409	1,472	1,587	1,481	2,541
Long-Term Debt	2,498	2,440	2,340	2,240	1,737	1,997	1,902	1,806	1,709	1,611	1,513	1,413	1,313	1,212	1,110	1,007	903	798	692	585	478	369	260	149	41	4,165	4,082	4,020	3,959	4,622	4,514	4,419	4,309	4,202
Liabilities	7,592	10,212	5,845	6,171	5,194	7,324	4,580	4,560	4,553	5,709	3,971	4,451	3,913	4,949	3,948	4,177	4,105	5,421	3,345	4,577	4,071	5,145	3,156	4,499	3,839	9,822	7,095	7,997	9,497	13,024	7,801	8,974	8,469	9,050
Stockholders' Equity	12,307	13,465	13,751	14,139	14,822	15,610	16,176	16,528	17,020	17,727	18,044	17,886	18,635	19,528	20,032	20,008	20,124	20,576	20,644	19,586	20,240	22,065	22,515	23,017	23,439	24,577	24,896	24,861	25,995	27,559	27,433	27,696	28,720	30,084


Income Statement ($'000)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue	8,218	9,884	6,847	6,005	7,882	10,262	490	6,312	8,178	10,441	7,773	5,921	8,813	10,432	8,761	6,002	8,739	10,837	8,410	6,750	8,724	12,207	581	8,392	9,903	11,652	545	8,384	11,399	13,182		9,081	10,945	12,503
Cost of Revenue	5,240	6,538	4,995	3,863	10	10	10	10	10	10	10	10	10	10	10	10	10	7,274	10	4,368	5,053	7,307	10	5,257	5,624	7,542	6,013	5,406	6,745	8,671		5,660	6,428	8,097
Gross Profit	2,978	3,346	1,852	2,142	2,865	3,264	2,356	2,241	2,972	3,182	2,493	2,088	3,431	3,593	3,018	2,037	3,164	3,562	2,577	2,382	3,671	4,900	2,921	3,135	4,278	4,110	2,974	2,978	4,654	4,511		3,421	4,517	4,406
R&D																													10	10
SG&A	1,674	1,241	972	1,056	1,604	1,306	1,161	1,150	1,879	1,552	1,348	1,152	2,132	1,615	1,641	1,422	2,057	2,351	1,750	2,486	1,794	1,911	1,469	1,544	1,984	2,011	1,759	1,555	2,289	2,109		1,700	2,212	2,149
Tax	224	479	76	386	446	389	140	179	92	351	194	130	168	426	232	87	53	144	53	0	346	674	248	236	617	529	125	156	364	358		209	285	319
Net Income	389	1,138	217	364	363	771	464	349	173	629	318	224	411	903	511	-16	114	296	67	-541	657	1,528	451	504	953	854	293	523	1,121	1,272		715	1,010	1,125


Cash Flow ($'000)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating		-397	2,524	-410	1,758	-1,411	2,838	-752	784	-298	2,832	-3	717	-423	1,495	-605	1,246	-1,625	1,785	138	96	-497	3,289	363	-245			522	-1,498	-180		-606	865	1,329
Cash Investing		-70	-159	-90	-139	-145	-396	-119	-209	-307	-37	-183	-293	-349	-155	-316	-306	-180	-152	-76	-81	-101	-186	-905	-1,629			-572	-344	-641		-304	-125	-98
Cash Financing		741	-2,591	600	-1,173	1,200	-1,708	-101	-102	278	-403	-40	-543	-103	-104	-105	-110	-112	-111	-91	-653	-113	-121	-117	-664			-66	480	1,530		-98	-180	-533